Loading stock data…
$82.13+0.57 (+0.71%)
LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. in the Healthcare sector is trading at $82.12 with a market capitalization of $1.8B. Wall Street consensus targets $107.00 (7 analysts), implying a +30.3% move over the next 12 months. The stock is currently near its 52-week low of $78.22, remaining 12.7% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $70.38M↑ | $66.55M↑ | $64.45M↑ | $61.05M↓ | $64.23M |
| Gross Profit | $50.76M↑ | $48.40M↑ | $46.19M↑ | $45.95M↑ | $44.97M |
| Operating Income | $20.40M↑ | $17.77M↓ | $18.83M↓ | $20.31M↑ | $16.14M |
| Net Income | $17.05M↑ | $15.68M↑ | $15.58M↓ | $17.36M↑ | $13.78M |
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreser...